Druggio Logo

Druggio

Astellas Pharma

Astellas Pharma is a global pharmaceutical company with a focus on advancing the field of pharmaceutical research and development. The company is known for its innovative drugs and treatments for various medical conditions, including urology, oncology, immunology, and infectious diseases. Astellas Pharma has a history of developing medications for conditions such as overactive bladder, prostate cancer, transplant rejection, and fungal infections. Founded in 2005 through the merger of two Japanese pharmaceutical companies, Astellas has since expanded its operations to become a well-respected leader in the healthcare industry.

Astellas Pharma's Drugs

Betanis

Approval date

2011/7/1

Blincyto

Approval date

2018/9/21

Celecox

Approval date

2007/1/26

Dafclir

Approval date

2018/7/2

Evenity

Approval date

2019/1/8

Treats

Osteoporosis
Evrenzo

Approval date

2019/9/20

Treats

Renal anemia
Funguard

Approval date

2002/10/8

Gonax

Approval date

2012/6/29

Kiklin

Approval date

2012/3/30

Linzess

Approval date

2016/12/19

Myslee

Approval date

2000/9/22

Treats

Insomnia
Orfadin

Approval date

2014/12/26

Treats

Tyrosinemia
Padcev

Approval date

2021/9/27

Polyful, Colonel

Approval date

2000/7/3

Recalbon, Bonoteo

Approval date

2009/1/21

Treats

Osteoporosis
Regnite

Approval date

2012/1/18

Repatha

Approval date

2016/1/22

Smyraf

Approval date

2019/3/26

Suglat

Approval date

2014/1/17

Vesicare

Approval date

2006/4/20

Xospata

Approval date

2018/9/21

Xtandi

Approval date

2014/3/24